GFD-78233-99376
2 vaccinations
3 coded responses
16 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 285 / NC
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
- 2020-12-22
-
2020-12-28
Health check-in — day 7, dose 1Feeling: Poor · Nausea, Vomiting, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2020-12-28
Report sent to call center — day 7, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-04
-
2021-01-11
Dose 2 — Pfizer-BioNTech
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-19
-
2021-01-25
Survey response — day 14, dose 2MedDRA: Headache — Feeling: Fair · Be unable to workFree text: HeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-01
- 2021-02-09
- 2021-02-15
- 2021-02-23
- 2021-04-14
-
2021-07-12
Survey response — 6 months, dose 2MedDRA: Sinus congestion — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Sinus congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-12
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-13
-
2022-01-11
Survey response — 12 months, dose 2MedDRA: Respiratory tract congestion — Feeling: Fair · Be unable to work or attend schoolFree text: CongestionMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech |
Call center
2 call center cases
1 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 2 — day 14, dose 2
Symptoms: Headache
Release 9 — 6 months, dose 2
Symptoms: Sinus congestion
Release 10 — 12 months, dose 2
Symptoms: Congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sinus congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release